View in EDS

Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216).

Saved in:
Bibliographic Details
Title: Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216).
Authors: Lutz MP; Caritasklinikum St. Theresia and Saarland University Medical Center, Saarbrücken and Homburg, Germany. m.lutz@caritasklinikum.de., Ansorge N; St. Elisabeth-Krankenhaus, Köln, Germany., Barmashenko G; AIO-Studien-gGmbH, Berlin, Germany., Bauer H; Staburo GmbH, München, Germany., Burkart C; Schwarzwald-Baar-Klinikum Villingen-Schwenningen, Villingen-Schwenningen, Germany., Decker T; Gemeinschaftspraxis für Hämatologie und Onkologie, Ravensburg, Germany., Ettrich T; Universitätsklinikum Ulm, Ulm, Germany., Fischer von Weikersthal L; Klinikum St. Marien Amberg, Amberg, Germany., Geer T; Diak Klinikum Landkreis Schwäbisch Hall, Schwäbisch Hall, Germany., Gerhardt A; Schwerpunktpraxis für Hämatologie und Onkologie, Potsdam, Germany., Höfling S; CROLLL GmbH, Nürnberg, Germany., Jacobasch L; Gemeinschaftspraxis Hämatologie-Onkologie, Dresden, Germany., Koenigsmann M; Onkologisches Ambulanzzentrum, Hannover, Germany., Leidig T; CROLLL GmbH, Nürnberg, Germany., Plentz R; Klinikum Bremen-Nord, Bremen, Germany., Räth S; AIO-Studien-gGmbH, Berlin, Germany., Reichert D; Gemeinschaftspraxis für Hämatologie und Onkologie, Westerstede, Germany., Schulte M; CROLLL GmbH, Nürnberg, Germany., Schulte N; Universitätsmedizin Mannheim, Mannheim, Germany., Schwarzer A; Onkopraxis Probstheida, Leipzig, Germany., Siegler G; Klinikum Nürnberg Paracelsus Medizinische Privatuniversität, Nürnberg, Germany., Waldschmidt D; Klinik für Gastroenterologie und Hepatologie der Uniklinik Köln, Köln, Germany., Karthaus M; München Klinik Neuperlach, München, Germany.
Source: British journal of cancer [Br J Cancer] 2026 Jan; Vol. 134 (1), pp. 85-91. Date of Electronic Publication: 2025 Oct 14.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41087530
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lutz+MP%22">Lutz MP</searchLink>; Caritasklinikum St. Theresia and Saarland University Medical Center, Saarbrücken and Homburg, Germany. m.lutz@caritasklinikum.de.<br /><searchLink fieldCode="AU" term="%22Ansorge+N%22">Ansorge N</searchLink>; St. Elisabeth-Krankenhaus, Köln, Germany.<br /><searchLink fieldCode="AU" term="%22Barmashenko+G%22">Barmashenko G</searchLink>; AIO-Studien-gGmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bauer+H%22">Bauer H</searchLink>; Staburo GmbH, München, Germany.<br /><searchLink fieldCode="AU" term="%22Burkart+C%22">Burkart C</searchLink>; Schwarzwald-Baar-Klinikum Villingen-Schwenningen, Villingen-Schwenningen, Germany.<br /><searchLink fieldCode="AU" term="%22Decker+T%22">Decker T</searchLink>; Gemeinschaftspraxis für Hämatologie und Onkologie, Ravensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Ettrich+T%22">Ettrich T</searchLink>; Universitätsklinikum Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Fischer+von+Weikersthal+L%22">Fischer von Weikersthal L</searchLink>; Klinikum St. Marien Amberg, Amberg, Germany.<br /><searchLink fieldCode="AU" term="%22Geer+T%22">Geer T</searchLink>; Diak Klinikum Landkreis Schwäbisch Hall, Schwäbisch Hall, Germany.<br /><searchLink fieldCode="AU" term="%22Gerhardt+A%22">Gerhardt A</searchLink>; Schwerpunktpraxis für Hämatologie und Onkologie, Potsdam, Germany.<br /><searchLink fieldCode="AU" term="%22Höfling+S%22">Höfling S</searchLink>; CROLLL GmbH, Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jacobasch+L%22">Jacobasch L</searchLink>; Gemeinschaftspraxis Hämatologie-Onkologie, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Koenigsmann+M%22">Koenigsmann M</searchLink>; Onkologisches Ambulanzzentrum, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Leidig+T%22">Leidig T</searchLink>; CROLLL GmbH, Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Plentz+R%22">Plentz R</searchLink>; Klinikum Bremen-Nord, Bremen, Germany.<br /><searchLink fieldCode="AU" term="%22Räth+S%22">Räth S</searchLink>; AIO-Studien-gGmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Reichert+D%22">Reichert D</searchLink>; Gemeinschaftspraxis für Hämatologie und Onkologie, Westerstede, Germany.<br /><searchLink fieldCode="AU" term="%22Schulte+M%22">Schulte M</searchLink>; CROLLL GmbH, Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schulte+N%22">Schulte N</searchLink>; Universitätsmedizin Mannheim, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Schwarzer+A%22">Schwarzer A</searchLink>; Onkopraxis Probstheida, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Siegler+G%22">Siegler G</searchLink>; Klinikum Nürnberg Paracelsus Medizinische Privatuniversität, Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Waldschmidt+D%22">Waldschmidt D</searchLink>; Klinik für Gastroenterologie und Hepatologie der Uniklinik Köln, Köln, Germany.<br /><searchLink fieldCode="AU" term="%22Karthaus+M%22">Karthaus M</searchLink>; München Klinik Neuperlach, München, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2026 Jan; Vol. 134 (1), pp. 85-91. <i>Date of Electronic Publication: </i>2025 Oct 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41087530
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-025-03188-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 85
    Titles:
      – TitleFull: Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lutz MP
      – PersonEntity:
          Name:
            NameFull: Ansorge N
      – PersonEntity:
          Name:
            NameFull: Barmashenko G
      – PersonEntity:
          Name:
            NameFull: Bauer H
      – PersonEntity:
          Name:
            NameFull: Burkart C
      – PersonEntity:
          Name:
            NameFull: Decker T
      – PersonEntity:
          Name:
            NameFull: Ettrich T
      – PersonEntity:
          Name:
            NameFull: Fischer von Weikersthal L
      – PersonEntity:
          Name:
            NameFull: Geer T
      – PersonEntity:
          Name:
            NameFull: Gerhardt A
      – PersonEntity:
          Name:
            NameFull: Höfling S
      – PersonEntity:
          Name:
            NameFull: Jacobasch L
      – PersonEntity:
          Name:
            NameFull: Koenigsmann M
      – PersonEntity:
          Name:
            NameFull: Leidig T
      – PersonEntity:
          Name:
            NameFull: Plentz R
      – PersonEntity:
          Name:
            NameFull: Räth S
      – PersonEntity:
          Name:
            NameFull: Reichert D
      – PersonEntity:
          Name:
            NameFull: Schulte M
      – PersonEntity:
          Name:
            NameFull: Schulte N
      – PersonEntity:
          Name:
            NameFull: Schwarzer A
      – PersonEntity:
          Name:
            NameFull: Siegler G
      – PersonEntity:
          Name:
            NameFull: Waldschmidt D
      – PersonEntity:
          Name:
            NameFull: Karthaus M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 134
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1